supplementary prescribing
Recently Published Documents


TOTAL DOCUMENTS

129
(FIVE YEARS 8)

H-INDEX

17
(FIVE YEARS 0)

2021 ◽  

Written by a group of multi-professional authors, this fully updated third edition builds on the success of this classic text. The book explores a number of key areas for prescribers, including prescribing within a multidisciplinary team context, consultation skills, ethical and legal issues surrounding prescribing, the psychology and sociology of prescribing, and applied pharmacology. Among the other topics featured are monitoring skills, medicines concordance, evidence based prescribing, prescribing within a public health perspective, calculation skills, prescribing in dermatology, and minimizing the risk of prescribing errors. Each chapter has been revised and additional chapters on antimicrobial prescribing, education and training to become a prescriber, and a new section on renal impairment have been added. This book is an essential resource for both new and experienced prescribers and anyone undertaking the non-medical prescribing (NMP) programme including nurses, pharmacists, allied health professionals and optometrists.


2021 ◽  
Vol 3 (2) ◽  
pp. 99-99
Author(s):  
Lyudmila K. Peshekhonova ◽  
Dmitry V. Peshekhonov ◽  
Alexander O. Pyatibrat ◽  
Nikolay G. Vengerovich

Correction in Peshekhonova L.K., Peshekhonov D.V., Pyatibrat A.O., Vengerovich N.Г. Comparison of the effectiveness of supplementary prescribing the chonodoprotector Mucosat in the oral and parenteral dosage forms during the acute exacerbation of osteoarthritis // Pharmacy Formulas. 2021. Vol. 3. N. 1. P. 6675. doi: https://doi.org/10.17816/phf60598.


2021 ◽  
Author(s):  
Lyudmila K. Peshekhonova ◽  
Dmitry V. Peshekhonov ◽  
Alexander O. Pyatibrat ◽  
Nikolai Vengerovich

The study aims to compare the methods of Mucosat drug use and administration for achieving the desired therapeutic effect in the treatment of osteoarthritis. Despite extensive evidence base, improving complex therapy schemes for the use of successive and complementary dosage forms with the appropriate drug administration and use in order to achieve the desired therapeutic effect is still a valid aim. In the course of the study, 50 knee osteoarthritis patients were examined and treated during the period from November, 2019 to April, 2020. A clinical trial was carried out to assess Mucosat oral and parental administration effectiveness in the patients comparing their physical activity, functional ability and quality of life. The number of undesired side effects identified the degree of therapeutic tolerance against the comorbid diseases identified. A comparison of the therapeutic efficacy and tolerability of Musocat intramuscular and capsule administration, patient compliance, the need to take non-steroidal anti-inflammatory drugs (NSAIDs) was drawn. Statistica 12 and Excel 2016 were used to carry out the statistical analysis of the data obtained. The study was generally marked by diagnostic accuracy with the use of modern methods, group homogeneity, prospective observational design. By the time of pharmacotherapy completion, physical activity has become optimal in the study groups. However, parental therapy had significantly higher effectiveness than the oral one on all the subscales. As a result, articular syndrome severity has been reduced and the functional state of the joints expanded. The study has shown that Mucosat demonstrates high efficacy both in injectable solution and capsule dosage forms as a basic chondroprotective drug. Mucosat pharmacotherapy course has contributed to permanent discontinuation of NSAIDs before completion of the therapy. The superiority of Mucosat parenteral administration over the oral one has been proven.


Author(s):  
Hung Phuc Nguyen ◽  
HUONG VO THI MY ◽  
THANH PHAN CHI

Objective: Examining and comparing the primary and supplementary prescribing indicators in pediatric outpatients under six years old. Methods: We performed a comparative cross-sectional study, over nine months, from September 2015. 800 prescriptions for peadiatric patients under 6 y old were collected at 8 district hospitals in Can Tho city to evaluate the primary and supplementary prescribing indicators. The sample was collected prospectively by the systematic selection, with the interval between the patients is 5. The data was analysed and compared to the standard drug use indicators in developing countries recommended by WHO. Results: Average number of drugs per encounter: 4.1, percentage of drugs prescribed by generic name: 94.2%, percentage of encounters with an antibiotic prescribed: 85.8%, percentage of drugs prescribed from essential drugs list by Ministry of Health: 78.7%, percentage of encounters with a corticoid prescribed: 41.7%, percentage of encounters with a vitamin prescribed: 13.1%, average drug cost per encounter: 37.5 thousands VND, percentage of drug costs spent on antibiotics: 55.2%, percentage of drug costs spent on essential drugs: 75.7%, percentage of drug costs spent on corticoid: 1.9%, percentage of drug costs spent on vitamin: 1.4%. Conclusion: The results of this research have identified some issues in outpatient prescribing, which may lead to intervention studies for evaluating changes in these issues in the outpatient clinic.


2019 ◽  
Vol 1 (1) ◽  
pp. 16-20
Author(s):  
Alison Culkin

In February 2016, registered dietitians in the UK gained supplementary prescribing rights. The aim of this case study is to describe the prescribing process by a registered dietitian supplementary prescriber. A 46-year-old male was transferred to a tertiary referral centre for a surgical review due to intra-abdominal tuberculosis resulting in bowel obstruction. The registered dietitian performed a nutritional assessment, estimated nutritional requirements and formulated a bag of parenteral nutrition to meet his needs. The patient remained an inpatient to complete a 6-month course of treatment for tuberculosis and then underwent surgery to resolve the obstruction. He was prescribed parenteral nutrition, which improved his nutritional status ready for restorative surgery. Post-operatively, he was weaned from parenteral nutrition onto an oral diet and was discharged.


2016 ◽  
Vol 14 (6) ◽  
pp. 294-299
Author(s):  
Martin McMahon ◽  
Geoff White

Sign in / Sign up

Export Citation Format

Share Document